FDA OK for Biomerica
- Share via
NEWPORT BEACH — Biomerica Inc. said Tuesday that it has received Food and Drug Administration clearance to market a nonradioactive test to detect and monitor certain thyroid diseases. The company develops, manufactures and markets diagnostic products for clinical labs, physician offices and home self-testing.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
